Cell & gene therapy

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Sitting Down With... Bruce Levine, Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.

We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.

Regulators step in to stop stem cell clinics from marketing unproven therapies.

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

Is gene therapy the answer to an untreatable form of macular degeneration?

Stem cells hold great promise, but is it the cells we really need?

What are the realities of translating exciting cell and gene therapy research into something more tangible?

Stem cells with a seasonal theme.

The gates for gene and cell therapies are open, and RNAi technology could be a serious contender